Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CPIX
CUMBERLAND PHARMACEUTICALS INC.
NASDAQ
$8.46
▼ DOWN 2.20% (-0.19)

KEY STATISTICS

Market Cap$126.76 M
52w High$9.28
52w Low$1.85
Dividend Yield19.31%
FrequencyIrregular
P/E-21.15
Volume47.85K
Shares Out.14.98M

COMPANY

LEADERSHIP

A. J. Kazimi
CHIEF EXECUTIVE
A. J. Kazimi

COMPENSATION 2026

Salary$702,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$2,269
Total$1,167,269

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 11, 2009
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
88

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$8.50M
NOV
3
TUE

PRICE

$8.46 ▼ DOWN 2.20% (−$0.19)
$8.60$8.80$9.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM8.46

About Cumberland Pharmaceuticals Inc.

https://www.cumberlandpharma.com ↗

Cumberland Pharmaceuticals Inc. develops and commercializes prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, including treatments for poisoning, pain, infections, constipation, and inflammatory diseases.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT CUMBERLAND PHARMACEUTICALS INC. IS KNOWN FOR

Talicia®
Talicia®

Talicia® is an FDA-approved oral capsule combining antibiotics and a proton pump inhibitor for H. pylori treatment, representing a key growth opportunity for Cumberland through its partnership with RedHill Biopharma.

COMPETITORS

COMPETITOR
ABBV COMPARE
ANIP COMPARE
PFE COMPARE
PHAT COMPARE
RDHL COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product Vibativ$3M $484.87K ▼$2.12M ▲$1.74M ▼
Product Other$306.51K $184.62K ▼$168.85K ▼$221.53K ▲

Revenue by Geography

MapREGIONQ1-2013Q2-2013
Segment Geographical Groups of Countries Group One$100K $100K

ETFS HOLDING THIS STOCK

ETFS HOLDING
17
LISTED HERE
4
RANKED BY POSITION SIZE
VTI
0.00% · 274.8K
DFAS
0.00% · 50.0K
IWC
0.02% · 29.3K
AVSC
0.00% · 3.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
25.86%
HOLDERS
52
TOP 12 OF 52 · RANKED BY POSITION SIZE
Millennium Management LLC
598.6K sh · $1.87M
Ikarian Capital, LLC
555.9K sh · $2.21M
Renaissance Technologies LLC
515.5K sh · $1.61M
Vanguard Group Inc
411.8K sh · $1.64M
Blackrock Institutional Trust Company, N.A.
381.7K sh · $2.1M
Perceptive Advisors LLC
341.1K sh · $1.36M
Dimensional Fund Advisors LP
280.9K sh · $876.31K
J. Goldman & Co LP
208.1K sh · $649.41K
Bridgeway Capital Management, LLC
188.4K sh · $587.67K
Boothbay Fund Management, LLC
168.1K sh · $524.57K
Geode Capital Management, LLC
114.3K sh · $371.5K
Blackrock Inc.
110.6K sh · $169.16K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Krogulski Kenneth
Purchase · 4.0K shares
2026-03-18
★
DIRECTOR
Galante Joseph C
Purchase · 1.8K shares
2026-03-18
★
DIRECTOR
Brown Martin S JR
Purchase · 1.8K shares
2026-03-18
★
DIRECTOR
Krogulski Kenneth
Purchase · 1.8K shares
2026-03-18

SECTORS PEERS

PEERPRICE
CELU$1.58COMPARE
RMTI$8.17COMPARE
LTRN$2.07COMPARE
DYAI$0.61COMPARE
ABVC$0.83COMPARE
QNTM$3.08COMPARE
CALC$0.46COMPARE
RVPH$0.52COMPARE